AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pulmonx Corp Director's Dealing 2022

Apr 7, 2022

34428_dirs_2022-04-07_850eca50-191d-48bd-bb8a-e7735f1dc90b.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-06-01

Reporting Person: Melenikiotou Georgia (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	29125	Direct